Sun Pharmaceutical Recalls Testosterone Cypionate Injection Due to Particulate Matter
Sun Pharmaceutical Industries, Inc. is recalling 83,188 vials of Testosterone Cypionate Injection due to the presence of particulate matter.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard is particulate matter without reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling 83,188 single-dose vials of Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL vial, for intramuscular use. The recall was initiated due to the presence of particulate matter in the product.
The affected product is distributed nationwide and is identified by lot codes JKR0744A, JKR0745A, JKR0750A, and JKR0795A, with an expiration date of 09/18. The product is manufactured by Sun Pharma Ind. Ltd. in India and distributed by Sun Pharma Ind. Inc. in New Jersey.
Consumers and healthcare providers should stop using the affected vials and contact Sun Pharmaceutical Industries, Inc. for further instructions or a refund.
The recalled product
- Product
- TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)
- Brand
- TESTOSTERONE CYPIONATE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Category
- Drug — Injection
- Hazard
- Affected units
- 83,188
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- JKR0744A
- JKR0745A
- JKR0750A
- JKR0795A
- Exp. 09/18
UPCs (3)
- 0362756017405
- 0362756015401
- 0362756016408
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TESTOSTERONE CYPIONATE
- ModerateTestosterone Cypionate Injection Recalled for Insoluble Crystals
FDA (Drugs) · 2025-04-23
- HighTestosterone Cypionate Injection Recalled for Manufacturing Defect
FDA (Drugs) · 2023-04-12
- HighTestosterone Cypionate Injection Recalled for Water Leakage in Manufacturing
FDA (Drugs) · 2022-07-20
- ModerateTestosterone Cypionate Injectable Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-07-13
- HighTestosterone Cypionate Injectable Recalled for Manufacturing Quality Issues
FDA (Drugs) · 2022-06-29
Same manufacturer · Sun Pharmaceutical Industries, Inc.
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26